title: Optimized preparation of celastrol-loaded polymeric nanomicelles using rotatable central composite design and response surface methodology.
abstract: Celastrol has been found to be a potent anti-inflammatory and antitumor plant derivative recently. Herein we established an accurate reverse phase HPLC (RP-HPLC) determination method of celastrol, and prepared an effective nanoscale drug delivery system from the optimized formulations of celastrol-loaded carboxyl functioned poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol)(PEO-block-PPO-block-PEO, Pluronic) polymeric nanomicelles. Rotatable central composite design (RCCD) and response surface methodology (RSM) were applied to improve the celastrol entrapment efficiency (EE), drug loading percentage (DLP), and decrease the particle size. The characteristics of the optimized micelles including particle size distribution, morphology, zeta potential and in vitro release of celastrol from micelles were carried out. Results showed that RP-HPLC method was successfully applied to detect and qualify the celastrol. The drug quantification range of the method was 20-200 microg/mL with a linear correlation coefficient of greater than 0.999. The average accuracy (99.763%), the precision (0.521%) and recovery (99.63%) for this method were good. The optimal conditions for the preparation of celastrol-loaded polymeric nanomicelles were found to be: the celastrol/polymer weight ratio 8.5-9 mg/25 mg, hydration volume 11-17 mL. Under the optimal conditions, the EE was 100.3 +/- 4.3%, DLP was 22.8 +/- 1.0%, the average particle size was 117.3 +/- 1.27 nm and the zeta potential was -2.19 +/- 0.15 mV. Transmission electron micrograph (TEM) showed the micelles to be oval and rodlike shaped, with mean diameter around 20 nm. The in vitro experiments proved that celastrol in polymeric nanomicelles released gradually over the period of 24 h. These results showed that the RCCD and RSM could efficiently be applied for optimized preparation of celastrol-loaded polymeric nanomicelles.
authors: Department of Laboratory Medicine, Shanghai First People's Hospital, Medical College, Shanghai Jiao Tong University Shanghai 200080, China.
authors: Xia
authors: X
authors: Peng
authors: Juan
authors: J
authors: Wang
authors: Hua
authors: H
authors: Song
authors: Daxiang
authors: D
authors: Cui
authors: Li
authors: L
authors: Li
authors: Jia
authors: J
authors: Li
authors: Lihui
authors: L
authors: Lin
authors: Juan
authors: J
authors: Zhou
authors: Yanan
authors: Y
authors: Liu
mesh_terms: D003692:Delayed-Action Preparations / Q000737:chemistry*; D004058:Diffusion; D004339:Drug Compounding / Q000379:methods; D008422:Materials Testing; D008823:Micelles; D053769:Nanocapsules / Q000737:chemistry* / Q000648:ultrastructure*; D053978:Pentacyclic Triterpenes; D011108:Polymers / Q000737:chemistry*; D014315:Triterpenes / Q000737:chemistry*
chemical_list: D003692:Delayed-Action Preparations; D008823:Micelles; D053769:Nanocapsules; D053978:Pentacyclic Triterpenes; D011108:Polymers; D014315:Triterpenes; C050414:celastrol